Safety and efficacy of reteplase for the treatment of acute arterial occlusion: Complexity of underlying lesion predicts outcome

Annals of Vascular Surgery

Volumn 19, Issue 6, 2005, Pages 817-822

  Hanover, Tod M ^a   Kalbaugh, Corey A ^a   Gray, Bruce H ^a   Langan III, Eugene M ^a   Taylor, Spence M ^a   Androes, Mark P ^a   Jones, W Tracey ^a   Blackhurst, Dawn W ^a  

^a GREENVILLE HOSPITAL SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; RETEPLASE;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ARTERIOGRAPHY; ARTERY THROMBOSIS; BLEEDING; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DEATH; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; ENDOVASCULAR SURGERY; FEMALE; FIBRINOLYTIC THERAPY; HEMATOMA; HUMAN; INGUINAL REGION; KAPLAN MEIER METHOD; KIDNEY FAILURE; LEG ISCHEMIA; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROPERITONEAL HEMATOMA; SURGICAL TECHNIQUE; SURVIVAL; THROMBECTOMY; TIME SERIES ANALYSIS; TRANSFUSION; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 27644504462     PISSN: 08905096     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10016-005-8047-2     Document Type: Conference Paper

References (13)

1. Dotter CT, Rosch J, Seaman AJ. Selective clot lysis with low-dose streptokinase. Radiology 1974;111:31-37.
2. STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity: the STILE trial. Ann Surg 1994; 220:251-268.
3. Ouriel K, Veith FJ, Sasahara AA. Thrombolysis or peripheral arterial surgery: phase I results. TOPAS investigators. J Vasc Surg 1996;23:64-75.
4. Ouriel K, Gray B, Clair D. Complications associated with the use of urokinase and recombinant TPA for catheter-directed peripheral arterial and venous thrombolysis. J Vasc Interv Radiol 2000;11:295-298.
5. Wooster MB, Luzier AB. Reteplase: a new thrombolytic for the treatment of acute myocardial infarction. Ann Pharmacother 1999;33:318-324.
6. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
7. Davidian M, Powell A, Benenati J, et al. Initial results of reteplase in the treatment of acute lower extremity arterial occlusions. J Vasc Interv Radiol 2000;11:289-294.
8. GUSTO 3 Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997;337:1118-1123.
9. Castaneda F, Swischuk JL, Li R, et al. Declining-dose study of reteplase treatment for lower extremity arterial occlusions. J Vasc Interv Radiol 2002;13:1093-1098.
10. Ouriel K, Katzen B, Mewissen M, et al. Reteplase in the treatment of peripheral arterial and venous occlusion: a pilot study. J Vasc Interv Radiol 2000;11:849-854.
11. Kasirajan K, Gray B, Beavers F, et al. Rheolytic thrombectomy in the management of acute and subacute limb threatening ischemia. J Vasc Interv Radiol 2001;12:413-421.
12. McNamara T, Dong P, Chen J, et al. Bleeding complications associated with the use of rt-PA versus r-PA for peripheral arterial and venous thromboembolic occlusions, techniques. Vasc Interv Radiol 2001;4:92-98.
13. Sullivan K, Gardiner G, Kandarpa K, et al. Efficacy of thrombolytics in infrainguinal bypass grafts. Circulation 1991;83:99-105.